Category: life extension – Page 485
Freezing cells made safer thanks to new polymer
Cell freezing (cryopreservation)—which is essential in cell transfusions as well as basic biomedical research—can be dramatically improved using a new polymeric cryoprotectant, discovered at the University of Warwick, which reduces the amount of ‘anti-freeze’ needed to protect cells.
The ability to freeze and store cells for cell-based therapies and research has taken a step forward in the paper “A synthetically scalable poly(ampholyte) which dramatically Enhances Cellular Cryopreservation.” published by the University of Warwick’s Department of Chemistry and Medical School in the journal Biomacromolecules. The new polymer material protects the cells during freezing, leading to more cells being recovered and less solvent-based antifreeze being required.
Cryopreservation of cells is an essential process, enabling banking and distribution of cells, which would otherwise degrade. The current methods rely on adding traditional ‘antifreezes’ to the cells to protect them from the cold stress, but not all the cells are recovered and it is desirable to lower the amount of solvent added.
Watch my “7 Signs of Longevity Revolution” keynote at Barclays
Longevity investor and visionary Sergey Young, founder of Longevity Vision Fund and Innovation Board Member of XPRIZE Foundation, delivers “7 Signs of Longevity Revolution” keynote at Barclay’s recent “Accelerating Evolution” conference, discussing recent developments in the longevity industry.
Watch to find out the forecasts for the industry’s trajectory of growth in the coming years, the increasing emergence of practical, real-world applications in the longevity sphere and how Longevity Vision Fund striving to be on the very forefront of the ongoing Longevity Revolution that is already happening around us today.
#longevity #lvf #longevityvisionfund #lifeextension #longevityrevolution #sergeyyoung #barclays
How your immortal consciousness will travel the universe
In about 100 years, theoretical physicist Michio Kaku believes we’ll explore the universe as pure consciousness — traveling at the speed of light, looking at asteroids, comets, meteors, and eventually the stars. “All of this within the laws of physics,” he says.
New Method of Halting α-Synuclein Aggregation
Researchers from the Beijing Institute of Brain Disorders have discovered a new method of using exosomes to deliver aptamers that prevent the accumulation of α-synuclein aggregates, which are the cause of Parkinson’s disease [1].
α-Synuclein Aggregates
Like Alzheimer’s, Parkinson’s disease is characterized by protein aggregation caused by a loss of proteostasis, one of the hallmarks of aging. In order for the brain to function properly, non-aggregated α-synuclein proteins are needed in order to facilitate the release of dopamine, a neurotransmitter, in nerve cell synapses. α-synuclein only becomes a problem when proteostasis fails and the proteins misfold, aggregate, and accumulate.
Neuroscientists reveal the number one exercise for slowing down the aging process
At a certain point in our lives all of us develop a negative relationship with the mirror on the wall. It just keeps showing too many lines, too many grey hairs and sagging stuff everywhere.
I know quite a few people who end up refusing to face the mirror for any reason whatever!
But we don’t all have to resort to such drastic measures, because there is something simple and enjoyable you can do to slow down the clock.
10 insights from my first 5 episodes of The Ageless Starman podcast
1. The 4 main things happening in Hyperbaric oxygen treatment: 1.- A decrease of inflammation 2.- An increase in the amount of oxygen in circulation and reversing hypoxia. 3.- Stimulate the release of stem cells from the brain along with the bone-derived stem cells. 4.- Kill infection. Why it matters for regenerative and dementia treatment? Listen to Dr. Scott Sherr explaining in detail in http://www.mendelhaim.com/podcast/2. For more information on Dr. Scott’s work go to https://www.hyperbaricmedicalsolutions.com/integrative-hbot/scott-sherr.
2. Raising money for academic research is a hard point, according to all of my guests, but even when we talk about Hyperbaric treatment there is a lack of money and the number of chambers declines in u.s. In Israel by the way, the demand is increasing and it takes a few months waiting in lines to start getting the treatment, this can turn into a big business opportunity in my opinion as to the risk for such research on participants is not as big as other medical research.
3. Longevity investment is a relatively new field and is lack of a method to invest by, the Three criteria that Sergey Young from the Longevity Vision Fund examine before investing in new companies are 1- will the product be affordable to touch millions of people’s lives and not only help the rich. 2- Looking for sectors that enjoy the technological exponential development paste such as AI, early diagnostics, stem cells, warbles, and organ transplants. 3 — Network, if you are a new startup and trying to raise from The Longevity vision fund, question yourself before, Do you have partners that can market your product such as big pharma or health care chain or a big manufacturer, do you collaborate with the best academic institutes in the longevity research. Go listen to the full episode Mission Alpha with Sergey Young on http://www.mendelhaim.com/podcast/3
